Fulcrum Therapeutics, Inc. (FULC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.18 | -637.5% |
| 2024 | $-0.16 | +89.9% |
| 2023 | $-1.59 | +34.8% |
| 2022 | $-2.44 | -6.6% |
| 2021 | $-2.29 | +17.9% |
| 2020 | $-2.79 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.18 | -637.5% |
| 2024 | $-0.16 | +89.9% |
| 2023 | $-1.59 | +34.8% |
| 2022 | $-2.44 | -6.6% |
| 2021 | $-2.29 | +17.9% |
| 2020 | $-2.79 | — |